Vital Signs - Expanding Personalized Medicine Outside of Oncologic PET
Vital Signs - Expanding Personalized Medicine Outside of Oncologic PET
RELEASE DATE
08-Sep-2008
08-Sep-2008
REGION
North America
North America
Research Code: 9561-00-70-00-00
SKU: HC00543-NA-MR_04015
$1,500.00
Special Price $1,125.00 save 25 %
In stock
SKU
HC00543-NA-MR_04015
Description
This issue of Vital Signs, released on September 8, 2008, provides an strategic overview of the expansion of personalized medicine outside of oncologic PET. Additionally, a company spotlight is provided for Cell>Point, a company focused on the development of novel radiopharmaceutical agents for diagnostic and therapeutic applications in neurology, cardiology and oncology. Reimbursement and regulatory news from the FDA is also provided for the week of August 26, 2008.
Table of Contents
This week's issue:
Popular Topics
This issue of Vital Signs, released on September 8, 2008, provides an strategic overview of the expansion of personalized medicine outside of oncologic PET. Additionally, a company spotlight is provided for Cell>Point, a company focused on the development of novel radiopharmaceutical agents for diagnostic and therapeutic applications in neurology, cardiology and oncology. Reimbursement and regulatory news from the FDA is also provided for the week of August 26, 2008.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | 9561-00-70-00-00 |
Is Prebook | No |